Currently out of the existing stock ratings of Dennis Ding, 29 are a BUY (64.44%), 16 are a HOLD (35.56%).

Dennis Ding

Work Performance Price Targets & Ratings Chart

Analyst Dennis Ding, currently employed at JEFFERIES, has had 65% of price targets met with an average potential upside of 24.1%, reached in 179 days on average.

Dennis Ding has documented 89 price targets and ratings displayed on 23 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ROIV, Roivant Sciences Ltd at 07-Sep-2026.

Wall Street Analyst Dennis Ding

Analyst best performing recommendations are on MIST (MILESTONE PHARMACEUTICALS).
The best stock recommendation documented was for NGM (NGM BIOPHARMACEUTICALS) on 10/17/2022. The price target of $4 was fulfilled within 3 days with a profit of $0.59 (17.3%), with a performance score of 57.67.

Average potential price target upside

ABUS Arbutus Biopharma Corp NGM NGM Biopharmaceuticals PRDS Pardes Biosciences ROIV Roivant Sciences Ltd CINC CinCor Pharma CORT Corcept Therapeutics LYRA Lyra Therapeutics SGTX Sigilon Therapeutics ASMB Assembly Biosciences FOLD Amicus Therapeutics MIST Milestone Pharmaceuticals RXRX Recursion Pharmaceuticals RYTM Rhythm Pharmaceuticals CRNX Crinetics Pharmaceuticals ESPR Esperion Therapeutics IMVT Immunovant MLYS Mineralys Therapeutics NAMS NewAmsterdam Pharma Company N.V. SG Sweetgreen VERU Veru ARDX Ardelyx TEVA Teva Pharma Industries Ltd ADR INDV Indivior PLC

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 15-Sep-2020

$5

$0.91 (22.25%)

$5

8 months 14 days ago
(04-Mar-2026)

10/15 (66.67%)

$0.25 (5.26%)

442

Buy Since 05-Nov-2021

$5

$5

1 years 7 months 18 days ago
(31-Mar-2025)

4/9 (44.44%)

$1.51 (43.27%)

420

Buy Since 17-Dec-2020

$5

$5

1 years 9 months 28 days ago
(21-Jan-2025)

5/19 (26.32%)

$1.79 (55.76%)

671

Hold Since 29-Dec-2021

$5

$4

4 years 9 months 16 days ago
(02-Feb-2022)

2/2 (100%)

$2.11 (73.01%)

1298

Buy Since 05-Mar-2020

$7

$7

5 years 4 months 21 days ago
(28-Jun-2021)

0/6 (0%)

$3.63 (107.72%)

Show more analysts

Please expand the browser size to see the chart

Which stock is Dennis Ding most bullish on?

Potential upside of $13.39 has been obtained for ROIV (ROIVANT SCIENCES LTD)

Which stock is Dennis Ding most reserved on?

Potential downside of -$2.57 has been obtained for TEVA (TEVA PHARMA INDUSTRIES LTD ADR)

What Year was the first public recommendation made by Dennis Ding?

On 2021
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?